Stockscreener 앱 받기
3.48
3.92%
-0.09
Cervomed Inc 주식(CRVO)의 최신 뉴스
Price to earnings forward of CervoMed Inc. – FWB:DP8 - TradingView
Price to book forward of CervoMed Inc. – NASDAQ:CRVO - TradingView
Price to book forward of CervoMed Inc. – DUS:DP8 - TradingView
Price to sales forward of CervoMed Inc. – NASDAQ:CRVO - TradingView
Enterprise value to EBITDA forward of CervoMed Inc. – NASDAQ:CRVO - TradingView
Enterprise value to EBITDA forward of CervoMed Inc. – DUS:DP8 - TradingView
Enterprise value to revenue forward of CervoMed Inc. – DUS:DP8 - TradingView
CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally - Stocktwits
CervoMed (CRVO) Schedule 13G: Manager-linked 750,000-share holding - Stock Titan
H.C. Wainwright Keeps Their Buy Rating on CervoMed (CRVO) - The Globe and Mail
CRVO stock rockets nearly 100% on patent win before offering news cools rally - MSN
CervoMed Inc. Actuals & Estimates (NASDAQ:CRVO) - TradingView
CRVO Forecast — Price Target — Prediction for 2027 - TradingView
Why did CRVO stock crash 22% in pre-market trading today? - MSN
CervoMed Inc (CRVO) Valuation: PE, PB & Fair Value Analysis - TradingKey
CervoMed Closes $10 Million Stock Offering - Moomoo
CervoMed closes $10 million registered direct offering By Investing.com - Investing.com Nigeria
CervoMed closes $10 million registered direct offering - Investing.com
CervoMed (NASDAQ: CRVO) closes $10M registered direct stock sale - Stock Titan
CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Moomoo
CervoMed Inc. Announces $10 Million Direct Offering of Common Stock and Placement Agent Warrants – June 2026 - Minichart
Form 424B5 CervoMed Inc For: 22 June By Investing.com - Investing.com Nigeria
CervoMed (NASDAQ: CRVO) seeks $10M via 2.5M-share offering; patent allowance noted - Stock Titan
CervoMed Announces $10 Million Registered Direct Offering; Engages H.C. Wainwright - TradingView
CervoMed shares surge after securing US patent protection for dementia therapy (CRVO) - MSN
CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
CRVO Stock Explodes As Insider Buying Fuels Biotech Momentum - timothysykes.com
CervoMed announces $10M registered direct offering priced at-the-market - TipRanks
CervoMed rises on patent news, pares gains after $10M equity sale - TechStock²
CervoMed Reports $10 Million Direct Offering of Shares - Moomoo
CervoMed prices $10M registered direct offering at $4/share By Investing.com - Investing.com India
CervoMed prices $10M registered direct offering at $4/share - Investing.com
CervoMed Announces $10 Million Registered Direct Offering - GlobeNewswire
CervoMed sells 2.5 million shares at $4.00 each to raise $10M - Stock Titan
CervoMed Inc. Receives Patent Allowance for Neflamapimod in Lewy Body Dementia, Securing IP Protection Through 2042 – Minichart - Minichart
CervoMed Shares Surge After Securing U.S. Patent Protection for Dementia Therapy (CRVO) - Yahoo Finance
CRVO Stock Soars As Insider Buy And Cash Raise Extend Runway - StocksToTrade
CRVO Stock Explodes As Insider Buy Fuels Biotech Momentum - timothysykes.com
3 Stocks To Watch Today: CRVO, SPRO, QNRX - RTTNews
CervoMed stock jumps 20% on new U.S. patent allowance By Investing.com - Investing.com Nigeria
CervoMed stock jumps 20% on new U.S. patent allowance - Investing.com UK
1.16%
0.48%
자본화:
|
볼륨(24시간):